Michael S. Rosol

2018

In 2018, Michael S. Rosol earned a total compensation of $11.5K as Chief Medical Officer at Navidea Biopharmaceuticals.

Compensation breakdown

Non-Equity Incentive Plan$2,949
Salary$8,542
Total$11,491

Rosol received $8.5K in salary, accounting for 74% of the total pay in 2018.

Rosol also received $2.9K in non-equity incentive plan.

Rankings

In 2018, Michael S. Rosol's compensation ranked 14,214th out of 14,244 executives tracked by ExecPay.

ClassificationRankingPercentile
All
14,214
out of 14,244
0th
Division
Manufacturing
5,759
out of 5,765
0th
Major group
Chemicals And Allied Products
2,127
out of 2,128
0th
Industry group
Drugs
1,816
out of 1,817
0th
Industry
In Vitro and In Vivo Diagnostic Substances
72
out of 72
0th
Source: SEC filing on June 28, 2019.

Rosol's colleagues

We found four more compensation records of executives who worked with Michael S. Rosol at Navidea Biopharmaceuticals in 2018.

2018

Michael Goldberg

Navidea Biopharmaceuticals

Chief Executive Officer

2018

Jed Latkin

Navidea Biopharmaceuticals

Chief Executive Officer

2018

Joel Kaufman

Navidea Biopharmaceuticals

Chief Business Officer

2018

Frederick Cope

Navidea Biopharmaceuticals

Chief Scientific Officer

News

You may also like